Health Press Release – Newsletter for January 14, 2011

European eHealth Week 2011: Registration Opens; Strong Support From Leading Hospitals and Associations

Key Stakeholders Make Decisive Leap Towards Europe's Largest eHealth Event (Budapest, Hungary, 10-12 May, 2011)

BRUSSELS and BUDAPEST, Hungary, January 13, 2011 – Registration is now open for the eHealth event of the year, eHealth Week
2011, which takes place in Budapest, Hungary on 10-12 May, 2011
(www.ehealthweek.org). The Hungarian Presidency of the Council of the
European Union, … Read the original article on Gaea Times at : European eHealth Week 2011: Registration Opens; Strong Support From Leading Hospitals and Associations.

Apollo Munich Health Insurance Wins Celent Model Insurer Asia 2011 Award

Winner in 'Policy Administration System' Category for Mastek's ElixirAsia Health Solution

MUMBAI, India, January 13, 2011 – Apollo Munich Health Insurance Co. Ltd. (AMHI), was
felicitated with the Celent Model Insurer Asia 2011 award in the Policy
Administration System (PAS) category. The award recognizes excellence in
technology best practices at insurers in Asia, in various categories.
[..] Read the original article: here.

Biosense Webster Successfully Completes First Clinical Atrial Fibrillation Ablation Cases in the European Union Using the THERMOCOOL(R) SMARTTOUCH(TM) Contact Force Sensing Catheter

THERMOCOOL(R) SMARTTOUCH(TM) Catheter from Biosense Webster Enables Contact Force Sensing in the Ablation of Atrial Fibrillation

WATERLOO, Belgium, January 13, 2011 – Biosense Webster, Inc., a Johnson & Johnson company, and a worldwide
leader in the diagnosis and treatment of cardiac arrhythmias, announced the
successful completion of the first clinical cases with the new THERMOCOOL(R)
SMARTTOUCH(TM) Contact Force … Original source on Gaea Times at : Biosense Webster Successfully Completes First Clinical Atrial Fibrillation Ablation Cases in the European Union Using the THERMOCOOL(R) SMARTTOUCH(TM) Contact Force Sensing Catheter.

Eisai Opens for Business in the Netherlands

Epilepsy Treatment Zonegran(R) First Commercially Available Product
HATFIELD, England, January 13, 2011 – Eisai Europe Limited, a subsidiary of Eisai Co., Ltd (Headquarters:
Tokyo; President and CEO: Haruo Naito) announces the establishment of its
sales and marketing operation in its wholly owned subsidiary in the
Netherlands based in Amsterdam. The first Eisai product on the Dutch market
is the … Read : Eisai Opens for Business in the Netherlands.